Hohimer Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.15M Buy
10,727
+267
+3% +$99K 0.41% 69
2026
Q1
$3.06M Sell
10,460
-3,819
-27% -$1.26M 0.36% 94
2025
Q4
$5.01M Sell
14,279
-40
-0.3% -$13.5K 0.67% 43
2025
Q3
$4.63M Buy
+14,319
New +$4.45M 0.65% 43
2024
Q4
Sell
-6,358
Closed -$3.31M 249
2024
Q3
$3.31M Sell
6,358
-3
-0% -$1.6K 0.71% 61
2024
Q2
$3.45M Buy
6,361
+4,309
+210% +$2.28M 0.8% 45
2024
Q1
$1.06M Buy
2,052
+39
+2% +$19.4K 0.25% 112
2023
Q4
$949K Buy
2,013
+19
+1% +$8.79K 0.24% 119
2023
Q3
$868K Buy
1,994
+39
+2% +$17.7K 0.25% 113
2023
Q2
$869K Sell
1,955
-54
-3% -$24.9K 0.24% 112
2023
Q1
$924K Sell
2,009
-2
-0.1% -$952 0.27% 97
2022
Q4
$1.03M Sell
2,011
-132
-6% -$67K 0.33% 65
2022
Q3
$973K Sell
2,143
-2
-0.1% -$957 0.31% 90
2022
Q2
$1.03M Sell
2,145
-2,482
-54% -$1.23M 0.31% 88
2022
Q1
$2.27M Hold
4,627
0.45% 78
2021
Q4
$2.15M Buy
4,627
+60
+1% +$25.2K 0.45% 77
2021
Q3
$1.7M Sell
4,567
-13
-0.3% -$4.94K 0.36% 92
2021
Q2
$1.75M Buy
4,580
+172
+4% +$65.7K 0.36% 93
2021
Q1
$1.58M Buy
4,408
+119
+3% +$38.3K 0.39% 83
2020
Q4
$1.38M Buy
4,289
+23
+0.5% +$7.06K 0.36% 90
2020
Q3
$1.25M Sell
4,266
-3,141
-42% -$845K 0.36% 95
2020
Q2
$1.95M Buy
7,407
+203
+3% +$54.2K 0.67% 44
2020
Q1
$1.95M Sell
7,204
-1,342
-16% -$366K 0.82% 42
2019
Q4
$2.58M Buy
+8,546
New +$2.35M 0.9% 16

Other funds holding ELV

Hohimer Wealth Management's ELV Position: Q2 2026 in Review

Hohimer Wealth Management increased its Elevance Health (ELV) stake by 2.6% in Q2 2026, buying an estimated $99K and bringing the position to 10,727 shares worth $4.15M. The position accounts for 0.41% of the portfolio, ranked #69.

Hohimer Wealth Management first reported a position in ELV in Q4 2019 and has held it in 24 quarters since. The position peaked at $5.01M in Q4 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hohimer Wealth Management held 10,727 shares of Elevance Health worth $4.15M as of Q2 2026.
  • Hohimer Wealth Management bought 267 Elevance Health shares in Q2 2026, an estimated $99K.
  • Elevance Health made up 0.41% of Hohimer Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Hohimer Wealth Management first reported a position in Elevance Health in Q4 2019 and has held it in 24 quarters since.
  • Hohimer Wealth Management's Elevance Health position peaked at $5.01M in Q4 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hohimer Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.